FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/22/2026
Back to search
Official data from USPTO
RHB PART
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/23/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
07/29/2022
Registration date
06/10/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2025
Last transaction
01/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
LAVACHE, LINDA M
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "RHB" in blue to the left of a design of a blue helix in the shape of an incomplete circle. Within the helix design is the wording "pART" in red. The color white represents background and/or transparent areas only and is not part of the mark.
Holders and representatives
Holders
Richter-Helm BioLogics GmbH. & Co. KG
Representatives
Haverly MacArthur Adams and Reese LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations for industrial use in manufacture; biological preparations for use in industry; nucleic recombinant acidsother than for medical and veterinary purposes
Class 5
Biotechnological preparations for medical use for the treatment of infectious and parasitic diseasesneoplasmscancerdiseases of the blood and blood-forming organsimmune disordersendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eyediseases of the eardiseases of the cardiovascularrespiratorygenitourinarydigestive systemsdiseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissueconditions relating to pregnancychildbirth and the puerperiumconditions originating in the perinatal periodcongenital malformationsdeformations and chromosomal abnormalitiespoisoning; biotechnological preparations for medical purposes for the treatment of infectious and parasitic diseasesneoplasmscancerdiseases of the blood and blood-forming organsimmune disordersendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eyediseases of the eardiseases of the cardiovascularrespiratorygenitourinarydigestive systemsdiseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissueconditions relating to pregnancychildbirth and the puerperiumconditions originating in the perinatal periodcongenital malformationsdeformations and chromosomal abnormalitiespoisoning; biotechnological preparationsnucleic recombinant acids for medical use
Class 42
Biotechnological research; testing of biological reagents for use in molecular biology
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/07/2026
FIMP
FINAL DISPOSITION PROCESSED
01/07/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/30/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
05/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2024
PUBO
PUBLISHED FOR OPPOSITION
05/21/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/08/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/18/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/18/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/18/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/18/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2024
GNFR
FINAL REFUSAL E-MAILED
02/01/2024
CNFR
FINAL REFUSAL WRITTEN
02/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/27/2023
RFNT
REFUSAL PROCESSED BY IB
07/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/06/2023
RFRR
REFUSAL PROCESSED BY MPU
07/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/26/2023
CNRT
NON-FINAL ACTION WRITTEN
05/25/2023
DOCK
ASSIGNED TO EXAMINER
05/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/31/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/22/2022
Continuous trademark protection
Get notified about every new filing that threatens RHB PART or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.